Signaling pathways
- BA3719 JB170Summary: JB170 is a potent and highly specific mediated degradation agent.
- BA3720 SP-96Summary: SP-96 is a potent, selective and ATP-competitive inhibitor.
- BA3721 CenisertibSummary: Cenisertib (AS-703569) is an ATP-competitive multikinase inhibitor that inhibits the activity of...
- BA3722 TAS-119Summary: TAS-119 is a potent, selective, and orally active inhibitor.
- BA3723 CCT129202Summary: CCT129202 is an aurora kinase inhibitor.
- BA3724 ChiauranibSummary: Chiauranib (CS2164) is an orally active multi-target inhibitor of tumor angiogenesis.
- BA3725 TinengotinibSummary: Tinengotinib is a modulator of one or more protein kinases, such as kinases and kinases.
- BA3726 CCT241736Summary: CCT241736 is a potent, orally available dual inhibitor.
- BA3727 CD532Summary: CD532 is a potent kinase inhibitor.
- BA3728 AKI603Summary: AKI603 is an aurora kinase A inhibitor.